Write your message
Volume 7, Issue 5 (September - October 2022)                   J Obstet Gynecol Cancer Res 2022, 7(5): 466-470 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghasemian S, Ghasemzadeh S, Soleimany A. Which is Responsible for Bradycardia in Woman Treated for Incomplete Abortion and Thrombocytopenia? Intravenous Immunoglobulins, Methylprednisolone or Clindamycin. J Obstet Gynecol Cancer Res. 2022; 7 (5) :466-470
URL: http://jogcr.com/article-1-449-en.html
1- Department of Obstetrics and Gynecology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran , dr.ghassemian@yahoo.com
2- Department of Obstetrics and Gynecology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran
Abstract:   (502 Views)

Clindamycin, IVIg, and corticosteroids are widely used in medicine. In this study, we represent an unusual case of sinus bradycardia following the administration of these drugs. The patient was a 31-year-old woman who presented a complaint of vaginal bleeding at Shahid Motahhari Hospital, Urmia, Iran. Vaginal examination revealed active bleeding. Laboratory tests reported a positive HCG level. Ultrasonography was performed, and the results showed the presence of retained products of conception. The patient became a candidate for curettage. The initial pulse rate was tachycardia. Laboratory data were reported, platelet count of 16000. corticosteroids and IVIgs were started. Due to the possibility of infectious abortion, Clindamycin and Gentamicin was started. About 24 hours after curettage and 4 hours after starting clindamycin, the patient felt dizziness. Vital signs were obtained that PR: 38-40. We concluded that clindamycin and IVIg can result in severe bradycardia, even in patients with no previous cardiac history, especially when combined with corticosteroids. As a result, we recommend physicians be more cautious when administrating these medications.

Full-Text [PDF 388 kb]   (34 Downloads) |   |   Full-Text (HTML)  (9 Views)  
Systematic Review: Case Report | Subject: Obstetrics and Gynecology
Received: 2021/07/20 | Accepted: 2021/11/21 | Published: 2022/07/7

1. Smieja M. Current indications for the use of clindamycin: A critical review. Can J Infect Dis. 1998;9(1):22-8. [DOI:10.1155/1998/538090] [PMID] [PMCID]
2. Lee JH, Lee SI, Chung CJ, Lee JH, Lee SC, Choi SR, et al. The synergistic effect of gentamicin and clindamycin on rocuronium-induced neuromuscular blockade. Korean J Anesthesiol. 2013;64(2):143-51. https://doi.org/10.4097/kjae.2013.64.2.143 [DOI:10.4097/kjae.2007.52.2.143] [PMID] [PMCID]
3. Zambrano D. Clindamycin in the treatment of obstetric and gynecologic infections: A review. Clin Ther. 1991;13(1):58-80.
4. Alikhani A, Salehifar E. An unreported clindamycin adverse reaction: Wrist monoarthritis. Iran J Pharm Res. 2012;11(3):959-62.
5. Laupland KB, Kirkpatrick AW, Delaney A. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med. 2007; 35: 2686-92. https://doi.org/10.1097/00003246-200712000-00002 [DOI:10.1097/01.CCM.0000295312.13466.1C] [PMID]
6. Pavone P, Passaniti E, Taibi R, Longo MR, Nunnari G,Verrotti A, Serra A, Falsaperla R, Cocuzza S. Intravenous immunoglobulin therapy when plasmapheresis fails in thrombotic thrombocytopenic purpura associated with severe ADAMTS 13 deficiency in childhood: a case report. Eur J Inflamm 2013;11:291-6. [DOI:10.1177/1721727X1301100131]
7. Cherin P, Marie I, Michallet M, Pelus E, Dantal J, Crave JC, et al. Management of adverse events in the treatment of patients with immunoglobulin therapy: a review of evidence. Autoimmun Rev. 2016;15(1):71-81. [DOI:10.1016/j.autrev.2015.09.002] [PMID]
8. Lyons PR, Newman PK, Saunders M. Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects. J Neurol Neurosurg Psychiatry.1988;51:285-7. [DOI:10.1136/jnnp.51.2.285] [PMID] [PMCID]
9. Galask RP, Larsen B. Infectious diseases in the female patient. Springer Science & Business Media; 2012.
10. Sivapalasingam S, Steigbigel NH. Macrolides, clindamycin, and ketolides. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 8th ed. Elsevier; 2015. p. 358-76. [DOI:10.1016/B978-1-4557-4801-3.00029-1]
11. Abishenganaden JA, Aitken ML, Arnold JM. Melmon and Morrelli's clinical pharmacology. McGraw-Hill, USA; 2000.
12. Meadowcroft AM, Diaz PR, Latham GS. Clostridium difficile toxin induced colitis after use of clindamycin phosphate vaginal cream. Ann Pharmacother. 1998;32(3):309-11. [DOI:10.1345/aph.17251] [PMID]
13. Galask RP, Larsen B. Infectious diseases in the female patient. Springer Science & Business Media; 2012.
14. Wagner JG, Novak E, Patel NC, Chidester CG, Lummis WL. Absorption, excretion and half-life of clindamycin in normal adult males. Am J Med Sci. 1968;256(1):25-37. [DOI:10.1097/00000441-196807000-00004] [PMID]
15. Sedigheh Ghasemian, Farzaneh Rashidi Fakari, Samira Jahangard, Elham Rajabi, Mohsen Ghasemian. Is Sinus Bradycardia a Side Effect of Clindamycin in Treatment of Septic Abortion? A Case Report. Jundishapur J Nat Pharm Prod. 2020;15(1):e68865. [DOI:10.5812/jjnpp.68865]
16. Guo Y, Tian X, Wang X and Xiao Z. Adverse Effects of Immunoglobulin Therapy. Front Immunol. 2018;9: 1299. [DOI:10.3389/fimmu.2018.01299] [PMID] [PMCID]
17. D'Andrea F, Ceccarelli M, Facciolà A, Paolucci I, Maranto D, Costantino ML, et al. Sinus bradycardia in a patient with bacterial meningitis in therapy with IVIg: a case report. Infect Dis Trop Med. 2019;5:e539.
18. Douedi S, Alshami A, Ashforth GF, Maludum O, Carson MP. Severe Symptomatic Bradycardia After Intravenous Immunoglobulin Infusion: A Rare Manifestation. J Cardiol and Cardiovasc Sci. 2020;4(1):14-7. [DOI:10.29245/2578-3025/2020/1.1185]
19. Taylor MR, Gaco D. Symptomatic sinus bradycardia after a treatment course of high-dose oral prednisone. J Emerg Med. 2013;45:e55-8. [DOI:10.1016/j.jemermed.2013.04.020] [PMID]
20. Akikusa JD, Feldman BM, Gross GJ, et al. Sinus bradycardia after intravenous pulse methylprednisolone. Pediatrics. 2007;119:e778-82. [DOI:10.1542/peds.2006-0029] [PMID]
21. Sodero A, Squitieri M, Mazzeo S, Pasca M, Matà S, Pieri F, Bessi V, Sorbi S. Acute symptomatic sinus bradycardia in high-dose methylprednisolone therapy in a woman with inflammatory myelitis: a case report and review of the literature. Clin Med Insights: Case Rep. 2019;12:1179547619831026. [DOI:10.1177/1179547619831026] [PMID] [PMCID]
22. Amartya Kundu, Timothy P, Fitzgibbons. Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report. Kundu and Fitzgibbons. J Med Case Rep. 2015;9:216. [DOI:10.1186/s13256-015-0701-x] [PMID] [PMCID]
23. Tvede N, Nielsen LP, Andersen V. Bradycardia after high-dose intravenous methylprednisolone therapy. Scand J Rheumatol. 1986;15:302-4. [DOI:10.3109/03009748609092597] [PMID]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/.

© 2022 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.